DrugPatentWatch Database Preview
Drugs in Development Information for CHS-828
» See Plans and Pricing
What is the drug development status for CHS-828?
CHS-828 is an investigational drug.
There have been 15 clinical trials for CHS-828.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 21st 2018.
The most common disease conditions in clinical trials are Psoriasis, Hyperemesis Gravidarum, and Arthritis, Rheumatoid. The leading clinical trial sponsors are Coherus Biosciences, Inc., Daiichi Sankyo Co., Ltd., and Baxalta US Inc.
There are nineteen US patents protecting this investigational drug and two hundred and sixty-three international patents.
Summary for CHS-828
| US Patents | 19 |
| International Patents | 263 |
| US Patent Applications | 35 |
| WIPO Patent Applications | 254 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2018-06-21) |
| Vendors | 53 |
Recent Clinical Trials for CHS-828
| Title | Sponsor | Phase |
|---|---|---|
| Treatment Strategies in CHS | Canadian Institutes of Health Research (CIHR) | Phase 4 |
| Treatment Strategies in CHS | University of Calgary | Phase 4 |
| Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo | Atrium Health | Phase 4 |
Clinical Trial Summary for CHS-828
Top disease conditions for CHS-828
Top clinical trial sponsors for CHS-828
US Patents for CHS-828
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CHS-828 | Start Trial | Compounds and compositions for the inhibition of NAMPT | Forma TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA) | Start Trial |
| CHS-828 | Start Trial | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA) | Start Trial |
| CHS-828 | Start Trial | Methods and compositions for treatment of demyelinating diseases | Pathologica LLC (San Francisco, CA) | Start Trial |
| CHS-828 | Start Trial | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA) | Start Trial |
| CHS-828 | Start Trial | N-cyano-N'-pyridylguanidines as serotonin antagonists | Leo Pharmaceutical Products Ltd. (Ballerup, DK) | Start Trial |
| CHS-828 | Start Trial | Cyanoguanidine prodrugs | Leo Pharmaceutical Products Ltd. A/S (Ballerup, DK) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CHS-828
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CHS-828 | Argentina | AR082885 | 2030-09-03 | Start Trial |
| CHS-828 | Australia | AU2011295725 | 2030-09-03 | Start Trial |
| CHS-828 | Brazil | BR112013004773 | 2030-09-03 | Start Trial |
| CHS-828 | Canada | CA2810038 | 2030-09-03 | Start Trial |
| CHS-828 | Chile | CL2013000588 | 2030-09-03 | Start Trial |
| CHS-828 | China | CN103384668 | 2030-09-03 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
